ADAR1 Capital Management »

Beyond Meat shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Beyond Meat (BYND) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Beyond Meat

Tip: Access up to 7 years of quarterly data

All positions including Beyond Meat held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beyond Meat by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.8k 577 8.28

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Beyond Meat

Parkwood
Susquehanna International
BlackRock
Vanguard Group
Wolverine Asset Management
Whitebox Advisors
State Street Corporation
Two Sigma Investments
Geode Capital Management
Goldman Sachs Group
Citigroup
Aristeia Capital
Bank of America Corporation
Citadel Advisors
National Bank Of Canada /fi/

View all funds holding Beyond Meat